Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”

This article was originally published in The Tan Sheet

Executive Summary

A group of FDA scientists is calling for the removal of agency leaders who are suspected of politically motivated decisions regarding the emergency contraceptive Plan B

Related Content

Advocates For Switching Birth Control Pill Face Social, Risk Obstacles
FDA Reorganization Elevates Scientific And Food Safety Priorities
Device Center Change May Cast Shadow On Woodcock's Future At CDER
Generic Rx Plan B Approval Points To Possible OTC Equivalents In Near Future
Hamburg Discusses FDA Top Priorities At HELP Confirmation Hearing
Sebelius Plans To Leave Plan B Decision To Science
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
HHS Nominee Sebelius Aims To Restore Science-based Approach At FDA
Plan B Ruling: Little Commercial Impact, Big Policy Implications





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts